Common Name | IPH-2201, IPH2201, NN-8765, NNC-0141-0000-0100, NNC-141-01000, anti-NKG2A, humZ270 |
---|---|
Synonyms | CD159A;NKG2;NKG2A |
Applications | Flow Cyt |
Recommended Dilutions | Flow Cyt 1:100 |
Formulation & Reconstitution | Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution. |
Host Species | Humanized |
IgG type | IgG4 |
Reactivity | Human |
Target | |
Uniprot ID | P26715 |
Description | Anti-NKG2A(monalizumab biosimilar) mAb |
Delivery | In Stock |
Storage & Shipping | Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature. |
Background | Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
Usage | Research use only |
Anti-NKG2A(monalizumab biosimilar) mAb
Price: 50μg $82.00 ; 100 μg $162.00
Product Data
Images
Figure 1. Flow cytometry analysis with 1 μg/mL Anti-NKG2A (monalizumab biosimilar) mAb (BME100085) on Expi293 cells transfected with Human NKG2A protein and Human CD94 protein (Blue histogram) or Expi293 transfected with irrelevant protein (Red histogram).